Seychelles Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Seychelles Health News.

Press releases published on October 28, 2026

3 hours ago

Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy

Indeterminate GlobeNewswire

4 hours ago

Bottled water continues to rank the highest among Americans’ most preferred beverages

Indeterminate GlobeNewswire

5 hours ago

Precipio Announces Q3-2026 Shareholder Update Call

Indeterminate GlobeNewswire

5 hours ago

 DBV Technologies publie ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités

Indeterminate GlobeNewswire

5 hours ago

DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

6 hours ago

STERIS Announces Dividend of $0.69 per share

Indeterminate GlobeNewswire

6 hours ago

LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession

Indeterminate GlobeNewswire

6 hours ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026

Indeterminate GlobeNewswire

6 hours ago

Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026

Indeterminate GlobeNewswire

6 hours ago

Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development

Indeterminate GlobeNewswire

6 hours ago

Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

6 hours ago

Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology

Indeterminate GlobeNewswire

6 hours ago

Teladoc Health Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

6 hours ago

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

6 hours ago

Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026

Indeterminate GlobeNewswire

6 hours ago

MIMEDX Announces Third Quarter 2026 Operating & Financial Results

Indeterminate GlobeNewswire

6 hours ago

Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Indeterminate GlobeNewswire

6 hours ago

MIMEDX Announces $25 Million Patent License Agreement

Indeterminate GlobeNewswire

6 hours ago

ARS Pharma to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire